about
The Role of Dietary Inflammatory Index in Cardiovascular Disease, Metabolic Syndrome and MortalityAnti-Inflammatory Effects of GLP-1-Based Therapies beyond Glucose ControlDendritic Cells and Their Role in Cardiovascular Diseases: A View on Human StudiesAntioxidants, inflammation and cardiovascular diseaseCell Systems to Investigate the Impact of Polyphenols on Cardiovascular HealthRhizoma Coptidis: A Potential Cardiovascular Protective AgentProgress and prospect of mesenchymal stem cell-based therapy in atherosclerosisThe Telomere/Telomerase System in Chronic Inflammatory Diseases. Cause or Effect?Redox Roles of Reactive Oxygen Species in Cardiovascular DiseasesComputational drug repositioning for peripheral arterial disease: prediction of anti-inflammatory and pro-angiogenic therapeutics.ABC Transport Proteins in Cardiovascular Disease-A Brief Summary.The stabilizing effect of an oligomeric proanthocyanidin on red blood cell membrane structure of poorly controlled Type II diabetesIgM antibodies to oxidized phosphatidylserine as protection markers in cardiovascular disease among 60-year olds.Exercise and eating habits among urban adolescents: a cross-sectional study in Kolkata, India.Chlorogenic acid protects against atherosclerosis in ApoE-/- mice and promotes cholesterol efflux from RAW264.7 macrophages.Two polymorphisms in the Fractalkine receptor CX3CR1 gene influence the development of atherosclerosis: a meta-analysisTetramethylpyrazine Protects against Hydrogen Peroxide-Provoked Endothelial Dysfunction in Isolated Rat Aortic Rings: Implications for Antioxidant Therapy of Vascular DiseasesIgM-antibodies against phosphorylcholine in mothers and normal or low birth weight term newborn infants.Antibodies against native and oxidized cardiolipin and phosphatidylserine and phosphorylcholine in atherosclerosis development.Orphan nuclear receptor Nur77 Inhibits Oxidized LDL-induced differentiation of RAW264.7 murine macrophage cell line into dendritic like cells.Characterization of lipid parameters in diabetic and non-diabetic atherosclerotic patients.Darbepoetin alpha reduces oxidative stress and chronic inflammation in atherosclerotic lesions of apo E deficient mice in experimental renal failure.Expression of suppressor of cytokine signaling genes in human elderly and Alzheimer's disease brains and human microgliaThe reduction of aorta histopathological images through inhibition of reactive oxygen species formation in hypercholesterolemia rattus norvegicus treated with polysaccharide peptide of Ganoderma lucidum.Red blood cell fatty acids and biomarkers of inflammation: a cross-sectional study in a community-based cohort.Immunoactivation at the crossroads of human diseaseAmelioration of Atherosclerosis by the New Medicinal Mushroom Grifola gargal Singer.Exploring the cellular basis of human disease through a large-scale mapping of deleterious genes to cell typesBeta-adrenergic receptor mediated inflammation control by monocytes is associated with blood pressure and risk factors for cardiovascular diseaseThe impact of maternal obesity during pregnancy on offspring immunity.Features of atherosclerosis in hemodialysis patients.Croton membranaceus Improves Some Biomarkers of Cardiovascular Disease and Diabetes in Genetic Animal Models.Plasma Biomarkers of Inflammation, the Kynurenine Pathway, and Risks of All-Cause, Cancer, and Cardiovascular Disease Mortality: The Hordaland Health StudyAnalysis of Soluble Molecular Fibronectin-Fibrin Complexes and EDA-Fibronectin Concentration in Plasma of Patients with Atherosclerosis.Genome-Wide Analysis of DNA Methylation and Cigarette Smoking in a Chinese Population.Meta-Analysis for the Association between Polymorphisms in Interleukin-17A and Risk of Coronary Artery DiseaseImmune mechanisms in atherosclerosis, especially in diabetes type 2Cytomegalovirus infection is associated with an increase in systolic blood pressure in older individuals.Pleiotropic Meta-Analyses of Longitudinal Studies Discover Novel Genetic Variants Associated with Age-Related Diseases.Oxidized Low-Density Lipoprotein (OxLDL)-Treated Dendritic Cells Promote Activation of T Cells in Human Atherosclerotic Plaque and Blood, Which Is Repressed by Statins: microRNA let-7c Is Integral to the Effect.
P2860
Q26741434-6F4C9EEC-E3A2-4B95-81B5-BFAF47FF5ED8Q26750746-27C6F2C2-FF35-4A83-980E-6AAD19D33B81Q26752811-07DDF286-CB62-474B-BDFE-A01A71909422Q26823009-7E981C6E-2531-43D9-ABF0-90C546557017Q26861363-347A7F89-A4CA-47B3-9186-025AC886A75CQ28067054-BE356EE8-4178-4398-994A-CA334D0CABBEQ28075184-3A41B1BD-7785-4893-A2F2-28F5A3E6DF1EQ28077460-51F9F597-139A-4123-BDA1-2E43DC8864F1Q28082072-8FD0538E-F743-4698-BA43-DDD40BF1FC6CQ30278668-FA4D7832-9054-4CF5-A0C8-248340E9D033Q30313271-852F8206-2C4B-4991-AE91-E2F0C8E18CD9Q30401960-CFDCE6C4-97FE-4F9C-9F9A-38CDF49DE126Q33590235-22AF1E50-E729-4BF3-BE10-DAC6123D3288Q33706392-ADD10C85-2133-495A-B0DB-1C9BCD40A037Q34133736-47B8F8EE-D318-4768-88C1-547AE890378EQ34152811-1C111DC9-5051-4AB4-B048-9194C3F8CE56Q34199298-B85842A7-9C28-41F3-8B60-341B048A8702Q34275789-248205C6-D00E-4DD6-B0E1-7C7C9797746AQ34634016-825A6168-F0CB-4682-8980-AB007F3917E5Q34762092-CA2A50C2-1A19-4C0C-9926-0D48B2BE0687Q35019676-9B7913F5-71CE-4888-9F41-A3893156EE64Q35106161-EE29910C-D5C5-4E04-B19B-C13C0AE562AFQ35272389-EAE3F74C-F84C-4F62-B3FC-CF3BC90B0309Q35678292-7081F854-3575-4C4F-923D-C75C724CFCE4Q35879822-CE450A7A-05A6-4EE4-8611-98A1E72A35CBQ35897390-2FA2FF56-AEAD-4F85-9C34-D11FACE0AC5FQ35910989-85941724-E374-47DE-A9FE-711E83436444Q36020174-B2360CD6-3101-4A90-827C-8C61E0A85135Q36244806-67326770-C46A-40C9-A8E2-C38DB6A09628Q36359747-E2A2555F-412D-4349-AC32-B1F817AC8D26Q36466087-C30B6DD4-E83E-455E-ADCF-2CC824AF3EBFQ36476384-79021967-60A0-4478-BE18-B4E4152C1A85Q36579036-0E18E2FE-9F89-425B-BE75-F5D6EC19E41AQ36943033-095FA16D-CE61-4C45-9F19-4CC5B18F3A36Q37077718-856306E9-6D16-4B4C-8EE0-057429B4B7A3Q37128843-D7654A73-1B9C-4ACC-85EA-01123862B0DAQ37261617-C3B2B2BC-7533-4DE7-8500-6DDC43A87B3DQ37265457-28F8E90F-F2B9-4178-BB73-A10E52A8D1DFQ37334893-5D40BA3F-4CE0-4A36-8688-48BCE4E0122BQ37364489-71B6B32C-2615-4CE1-BA42-D34033759555
P2860
description
2013 nî lūn-bûn
@nan
2013 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Immunity, atherosclerosis and cardiovascular disease
@ast
Immunity, atherosclerosis and cardiovascular disease
@en
Immunity, atherosclerosis and cardiovascular disease
@nl
type
label
Immunity, atherosclerosis and cardiovascular disease
@ast
Immunity, atherosclerosis and cardiovascular disease
@en
Immunity, atherosclerosis and cardiovascular disease
@nl
prefLabel
Immunity, atherosclerosis and cardiovascular disease
@ast
Immunity, atherosclerosis and cardiovascular disease
@en
Immunity, atherosclerosis and cardiovascular disease
@nl
P2860
P3181
P356
P1433
P1476
Immunity, atherosclerosis and cardiovascular disease
@en
P2093
Johan Frostegård
P2860
P2888
P3181
P356
10.1186/1741-7015-11-117
P407
P5008
P577
2013-05-01T00:00:00Z
P6179
1027152234